{"id":"W178626500","doi":"10.2165/00003088-200746020-00002","title":"Efavirenz and Nevirapine in HIV-1 Infection","year":2007,"lang":"en","type":"review","venue":"Clinical Pharmacokinetics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Nevirapine; Efavirenz; Medicine; Virology; Pharmacotherapy; Human immunodeficiency virus (HIV); Reverse-transcriptase inhibitor; Antiretroviral therapy; Pharmacology; Viral load; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008719611,0.0004674538,0.002064944,0.0003880359,0.00003210792,0.00001756722,0.00008005997,0.0004893997,0.0002028432],"category_scores_gemma":[0.0001961583,0.0003591553,0.0004216733,0.0004993443,0.0001554351,0.0000354362,0.0001135222,0.001083403,0.0003824203],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001230555,"about_ca_system_score_gemma":0.000203013,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002922896,"about_ca_topic_score_gemma":0.000003660662,"domain_scores_codex":[0.9970285,0.0001752649,0.001641171,0.0005677645,0.0002349448,0.0003524018],"domain_scores_gemma":[0.9984717,0.0005805735,0.0002876108,0.0002748798,0.00005246064,0.0003327896],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002944119,0.000505959,0.005965209,0.004843266,0.000260704,0.0002685725,0.00001318357,9.81449e-8,1.10622e-7,0.00001372441,0.00824149,0.9798582],"study_design_scores_gemma":[0.002606878,0.0001168914,0.001187132,0.006242055,0.002141346,0.0000778764,0.000001055459,0.00001978282,0.000001427703,0.00001086253,0.9872961,0.0002985701],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002196921,0.995216,0.00003904053,0.0002767169,0.0006037414,0.001142938,0.00001442179,0.00006922927,0.00241818],"genre_scores_gemma":[0.00002879436,0.9898515,0.0008346971,0.0003028679,0.0007491179,0.00004619729,0.000286515,0.00006708029,0.007833171],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9795597,"threshold_uncertainty_score":0.999886,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2110986145093175,"score_gpt":0.5207145243752711,"score_spread":0.3096159098659537,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}